Clinical Results of a Monofocal Aspheric Bitoric Intraocular Lens With Plate Haptics in Hyperopic Eyes (HIPER-AT-TORBI)

Last updated: March 21, 2024
Sponsor: OFTALVIST (Oftalmología Vistahermosa S.L)
Overall Status: Completed

Phase

N/A

Condition

Cataracts

Eye Disorders/infections

Eye Disease

Treatment

Implant of the AT-TORBI 709 lens

Clinical Study ID

NCT05058274
HIPER-AT-TORBI
  • Ages > 50
  • All Genders

Study Summary

Observational post-marketing study with prospective follow-up of CE marked medical devices aimed at the treatment of hyperopia and astigmatism in patients with cataract. The objective is to evaluate the clinical results of the implantation of the monofocal aspheric bitoric intraocular lens (IOL) with AT-TORBI 709 plate haptics in cataract surgery of hyperopic eyes with astigmatism.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patients of 50 years of age or older to undergo cataract surgery withphacoemulsification
  2. Patient who signs the informed consent.
  3. Regular corneal astigmatism between 1.0D and 4.0D.
  4. IOL power between 21D and 26D
  5. Target-target distance measured with the IOLMaster 700 biometer (Carl Zeiss MeditecAG) greater than 11.6 mm.
  6. Patients with hyperopia between 1.0D and 4.0D.

Exclusion

Exclusion Criteria:

  1. Patients who do not provide informed consent
  2. Patients who do not understand the study procedure
  3. Previous corneal surgery.
  4. Irregular cornea (eg keratoconus)
  5. myopic patients
  6. Eye abnormalities or pathologies that could reduce the visual function or stability ofthe IOL (eg severe amblyopia or macular degeneration)

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Implant of the AT-TORBI 709 lens
Phase:
Study Start date:
November 03, 2021
Estimated Completion Date:
February 21, 2024

Study Description

All patients participating in the study will have the intraocular lens (IOL) AT TORBI 709 implanted from Carl Zeiss Meditec AG, Jena, Germany, with CE marking. All patients will be treated according to standard clinical practice. A preoperative and postoperative evaluation will be carried out one month, six and twelve months after the intervention where the following tests will be performed: refraction, corneal topography, measurement of visual acuity with and without correction, slit lamp examination, eye biometry using the IOLMaster 700 Carl Zeiss Meditec AG, Jena, Germany, CE marked optical non-contact biometer, contrast sensitivity with the CC-100 screen (Topcon Europe, The Netherlands), and the Catquest-9SF (European Registry of Quality Outcomes for Cataract and Refractive Surgery, founded by the European Society of Cataract and Refractive Surgeons). The sponsor has received an unrestricted research grant by Zeiss.

Connect with a study center

  • OFTALVIST (Oftalmología Vistahermosa S.L.)

    Alicante, 03015
    Spain

    Site Not Available

  • OFTALVIST (Oftalmología Vistahermosa S.L.)

    Valencia, 46004
    Spain

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.